Evogene Reports Third Quarter 2024 Financial Results

2 days ago · Excluding Lavie Bio and Biomica, Evogene and its other subsidiaries used approximately $3.1 million in cash during the third quarter of 2024. Projected cash usage for …

CouponFollow Extension

$3
OFF

Evogene Reports Third Quarter 2024 Financial Results

5 days from now

2 days ago · Excluding Lavie Bio and Biomica, Evogene and its other subsidiaries used approximately $3.1 million in cash during the third quarter of 2024. Projected cash usage for …

evogene.com

$5
OFF

Evogene Ltd. (EVGN) Q3 2024 Earnings Call Transcript

5 days from now

2 days ago · The consolidated cash usage during the third quarter of 2024 was approximately $5.7 million, excluding Lavie Bio and Biomica, Evogene and its other subsidiaries used …

seekingalpha.com

$2
OFF

Evogene Reports Second Quarter 2024 Financial Results

5 days from now

Aug 22, 2024 · Excluding Lavie Bio and Biomica, Evogene and its other subsidiaries used approximately $2.7 million in cash during the second quarter of 2024. Projected cash usage …

evogene.com

$3
OFF

Evogene Reports Third Quarter 2024 Financial Results

5 days from now

2 days ago · Excluding Lavie Bio and Biomica, Evogene and its other subsidiaries used approximately $3.1 million in cash during the third quarter of 2024. Projected cash usage for …

lelezard.com

$5
OFF

Evogene Ltd. (NASDAQ:EVGN) Q3 2024 Earnings Call Transcript

5 days from now

The consolidated cash usage during the third quarter of 2024 was approximately $5.7 million, excluding Lavie Bio and Biomica, Evogene and its other subsidiaries used approximately $3.1 …

msn.com

$4
OFF

Intel Reports Third-Quarter 2024 Financial Results

5 days from now

Oct 31, 2024 · Q3 2024 Financial Highlights. In the third quarter, the company generated $4.1 billion in cash from operations and paid dividends of $0.5 billion. *Not meaningful. Q3 2024 …

intc.com

$6
OFF

AMD Reports Third Quarter 2024 Financial Results

5 days from now

Oct 29, 2024 · ZIP XLS HTML. SANTA CLARA, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced revenue for the third quarter of 2024 of $6.8 billion, …

amd.com

$6
OFF

Evogene Reports Third Quarter 2024 Financial Results

5 days from now

2 days ago · Conference call and webcast: today, November 21, 2024, 9:00 am ET Financial Highlights: In the first nine months of 2024, total revenues reached approximately $6.9 million, …

marketscreener.com

$52
OFF

Tevogen Bio Reports Third Quarter 2024 Financial Results;

5 days from now

4 days ago · November 19, 2024 16:50 ET | Source: Tevogen Bio Inc. Follow. Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 …

globenewswire.com

$3
OFF

Evogene Reports Third Quarter 2024 Financial Results

5 days from now

Excluding Lavie Bio and Biomica, Evogene and its other subsidiaries used approximately $3.1 million in cash during the third quarter of 2024. Projected cash usage for 2024, excluding Lavie …

agropages.com

$13
OFF

CAMP4 Reports Third Quarter 2024 Financial Results - BioSpace

5 days from now

2 days ago · Net loss was $13.5 million for the third quarter 2024, compared to $11.7 million for the same period in 2023. About CAMP4 Therapeutics. CAMP4 is developing disease …

biospace.com

29%
OFF

Roblox - Roblox Reports Third Quarter 2024 Financial Results

5 days from now

Oct 31, 2024 · Third Quarter 2024 Financial, Operational, and Liquidity Highlights. Revenue was $919.0 million, up 29% year-over-year. Bookings 1 were $1,128.5 million, up 34% year-over …

roblox.com

$3
OFF

Evogene Reports Third Quarter 2024 Financial Results

5 days from now

2 days ago · Excluding Lavie Bio and Biomica, Evogene and its other subsidiaries used approximately $3.1 million in cash during the third quarter of 2024. Projected cash usage for …

fox44news.com

$25
OFF

UroGen Pharma Reports 2024 Third Quarter Financial Results And …

5 days from now

Nov 6, 2024 · Third Quarter 2024 Financial Results. JELMYTO Revenue: JELMYTO net product revenues were $25.2 million and $20.9 million for the three months ended September 30, ...

urogen.com

$1
OFF

Evogene Reports Third Quarter 2024 Financial Results

5 days from now

2 days ago · Rhea-AI Summary. Evogene (EVGN) reported Q3 2024 financial results with total revenues of $1.8M in Q3 2024, down from $3.8M in Q3 2023. However, nine-month revenues …

stocktitan.net

$1
OFF

Yoshiharu Reports Third Quarter 2024 Financial Results

5 days from now

4 days ago · The Company’s cash balance totaled $1.7 million on September 30, 2024, compared to $1.4 million on December 31, 2023. For more information regarding Yoshiharu’s financial …

businessinsider.com

FAQs about Evogene Reports Third Quarter 2024 Financial Results Coupon?

How much money did Evogene spend in 2024?

The financing expenses in the first nine months of 2024 net included $0.88 million expenses related to accounting treatment of warrants issued as part of Evogene’s fundraising. Projected cash usage for 2024 without Biomica and Lavie Bio is approximately $8 million to $10 million compared to $12.5 million in 2023. ...

Does Evogene (evgn) miss earnings expectations in Q3 2024?

A close-up of a scientist in a lab coat manipulating computational predictive tools. Evogene Ltd. (NASDAQ:EVGN) Q3 2024 Earnings Call Transcript November 21, 2024 Evogene Ltd. misses on earnings expectations. Reported EPS is $-1.31 EPS, expectations were $-1.01. Operator: Welcome to Evogene’s Third Quarter Results Conference Call. ...

How did Evogene perform in Q3 2024?

For the full year 2024 Evogene anticipates continued revenue growth compared to the previous year, mainly due to Casterra supply of existing seed orders. G&A expenses in Q3 2024 included expenses of approximately $1.4 million resulting from Evogene's fundraising and an allowance for doubtful debt from one of Casterra's seed suppliers. ...

Why did Evogene's stock increase during the first nine months?

The increase during the first nine months period and the third quarter of 2024 were mainly attributable to expenses recorded in Casterra due to a provision on doubtful debt of one seed supplier and transaction costs related to the Evogene's fundraising that occurred in August 2024, totaling approximately $1.4 million. ...

How much money will Evogene make without Biomica & Lavie bio?

Projected cash usage for 2024 without Biomica and Lavie Bio is approximately $8 million to $10 million compared to $12.5 million in 2023. In August 2024 Evogene completed a fundraising totaling of $5.5 million in gross proceeds, including ordinary shares and two sets of warrants. ...

When will Duluth Holdings (dlth) report third quarter 2024 financial results?

MOUNT HOREB, Wis., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s casual wear, workwear and accessories, today announced that it will report third quarter 2024 financial results before market on Thursday, December 5, 2024. ...